Top Issues of 2023: Zero Emission Vehicles
With the 2022 Legislative Session rapidly approaching, MACo is profiling some major issues that stand to gather attention in the General Assembly. Maryland is one of the leading states when…
Statewide Candidates Talk Infrastructure, Public Safety, Economy, and More at #MACoCon Forum
With primary elections in the books, candidates for governor, attorney general, and comptroller addressed the MACo Summer Conference in a forum on issues of importance for county governments. Mileah Kromer,…
$3.7M Slated for Massive Maryland EV Charging Station Expansion
In a press release today, Governor Larry Hogan announced a total of $3.7M is being given to 37 sites to build electric vehicle charging stations throughout Maryland. “For more than…
Purdue Pharma Pleads Guilty to DOJ Criminal Charges in Opioid Case
The pharmaceutical company has pled guilty to federal criminal charges and agrees to pay $8.3 billion in penalties. Purdue Pharma has settled with the U.S. Department of Justice (DOJ) on…
Maker of Suboxone Reaches Largest Settlement Yet Related to Opioid Crisis
The maker of Subxone is the latest pharmaceutical company to settle rather than face trial for alleged. The company will pay $1.4 billion to the U.S government to settle --…
2022 End of Session Wrap-Up: Liability and Courts
The segments below provide a brief overview of MACo’s work in the area of liability and courts in the 2022 General Assembly. County governments enforce laws, employ county residents, and…
Harford Announces Legislation to Protect Farmland from Development
Harford County Executive Barry Glassman this week introduced legislation to protect more than 1,500 acres in the County from development. Harford County Executive Glassman sent legislation to the County Council…
States Moving Toward Accepting Purdue Pharma’s Bankruptcy
Purdue Pharma, the largest player in ongoing litigation over opioid manufacturer lawsuits, has proposed a complex bankruptcy - many states (but not yet including Maryland) have withdrawn initial opposition to…
